Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of CYP2C19 Genetic Variants on Clopidogrel in Healthy Subjects

NCT00413608 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT00413608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00413608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of CYP2C19 Genetic Variants on Clopidogrel in Healthy Subjects
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2007
Completion date
January 31, 2009
Enrollment
140 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy